Scott Tarriff, CEO: Eagle Pharmaceuticals EGRX Sell · Filed 23/10/04

Trade details

Type: Insider sale
Amount: $144,445.84
Shares · price: 10,024 sh · $14.41 a share
Held after: 567,776 sh
Stock: Eagle Pharmaceuticals EGRX
Person: Scott TarriffCEO
Trade date: 23/10/03
Filed: 23/10/04
Days to filing: 1 days

Sold 1.7% of holdings

Share of holding sold: 1.7%

Eagle Pharmaceuticals trades, last 26 weeks

What else happened in Eagle Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/09/03~23/11/02

Scott Tarriff's recent trades

Scott TarriffCEO
Sell10b5-1 planEagle Pharmaceuticals
Sell10b5-1 plan
Eagle Pharmaceuticals
EGRX
$151K
10,925 sh
$151K
Filed 23/11/03
Traded 23/11/01
Scott TarriffCEO
Sell10b5-1 planEagle Pharmaceuticals
Sell10b5-1 plan
Eagle Pharmaceuticals
EGRX
$148.3K
10,694 sh
$148.3K
Filed 23/11/03
Traded 23/11/02
Scott TarriffCEO
Sell10b5-1 planEagle Pharmaceuticals
Sell10b5-1 plan
Eagle Pharmaceuticals
EGRX
$144.9K
9,511 sh
$144.9K
Filed 23/10/04
Traded 23/10/02
Scott TarriffCEO
Sell10b5-1 planEagle Pharmaceuticals
Sell10b5-1 plan
Eagle Pharmaceuticals
EGRX
$10.7K
710 sh
$10.7K
Filed 23/10/04
Traded 23/10/03
Scott TarriffCEO
SellEagle Pharmaceuticals
Sell
Eagle Pharmaceuticals
EGRX
$299.7K
15,000 sh
$299.7K
Filed 23/05/18
Traded 23/05/16

Scott Tarriff, CEO — sold $144.4K of Eagle Pharmaceuticals EGRX · 1.7% of holdings · 10b5-1 plan | Whalegun